Advertisement
CAPN vs WST
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPN is a StrongBuy and WST is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CAPN’s FA Score shows that 0 FA rating(s) are green whileWST’s FA Score has 0 green FA rating(s).
- CAPN’s FA Score: 0 green, 5 red.
- WST’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CAPN’s TA Score shows that 1 TA indicator(s) are bullish while WST’s TA Score has 3 bullish TA indicator(s).
- CAPN’s TA Score: 1 bullish, 0 bearish.
- WST’s TA Score: 3 bullish, 5 bearish.
Price Growth
CAPN (@Financial Conglomerates) experienced а +0.19% price change this week, while WST (@Pharmaceuticals: Other) price change was -0.20% for the same time period.
The average weekly price growth across all stocks in the @Financial Conglomerates industry was +0.60%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was +16.53%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.55%. For the same industry, the average monthly price growth was -3.61%, and the average quarterly price growth was +8.33%.
Reported Earning Dates
WST is expected to report earnings on Oct 23, 2025.
Industries' Descriptions
@Financial Conglomerates (+0.60% weekly)Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.
@Pharmaceuticals: Other (-1.55% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| CAPN | WST | CAPN / WST | |
| Capitalization | 82M | 18.3B | 0% |
| EBITDA | N/A | 760M | - |
| Gain YTD | 4.179 | -22.120 | -19% |
| P/E Ratio | N/A | 38.10 | - |
| Revenue | N/A | 2.96B | - |
| Total Cash | 183K | 510M | 0% |
| Total Debt | N/A | 303M | - |
CAPN | WST | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 96 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 34 Fair valued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 49 | |
PRICE GROWTH RATING 1..100 | 56 | 49 | |
P/E GROWTH RATING 1..100 | 100 | 61 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CAPN's Valuation (34) in the Medical Specialties industry is somewhat better than the same rating for WST (86). This means that CAPN’s stock grew somewhat faster than WST’s over the last 12 months.
CAPN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as WST (100). This means that CAPN’s stock grew similarly to WST’s over the last 12 months.
WST's SMR Rating (49) in the Medical Specialties industry is somewhat better than the same rating for CAPN (100). This means that WST’s stock grew somewhat faster than CAPN’s over the last 12 months.
WST's Price Growth Rating (49) in the Medical Specialties industry is in the same range as CAPN (56). This means that WST’s stock grew similarly to CAPN’s over the last 12 months.
WST's P/E Growth Rating (61) in the Medical Specialties industry is somewhat better than the same rating for CAPN (100). This means that WST’s stock grew somewhat faster than CAPN’s over the last 12 months.
| CAPN | WST | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 62% |
| Stochastic ODDS (%) | N/A | 1 day ago 67% |
| Momentum ODDS (%) | N/A | 1 day ago 67% |
| MACD ODDS (%) | 1 day ago 18% | 1 day ago 53% |
| TrendWeek ODDS (%) | 1 day ago 10% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 11% | 1 day ago 68% |
| Advances ODDS (%) | N/A | 11 days ago 67% |
| Declines ODDS (%) | N/A | 4 days ago 59% |
| BollingerBands ODDS (%) | N/A | 1 day ago 70% |
| Aroon ODDS (%) | N/A | 1 day ago 64% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPSL | 26.82 | -0.01 | -0.04% |
| Calamos Laddered S&P 500 Str Alt Prt ETF | |||
| RAVI | 75.55 | -0.04 | -0.05% |
| FlexShares Ultra-Short Income ETF | |||
| IGHG | 78.83 | -0.09 | -0.11% |
| ProShares Investment Grade—Intr Rt Hdgd | |||
| LDRC | 25.31 | -0.05 | -0.20% |
| iShares iBonds 1-5 Year Corporate Ladder ETF | |||
| BBBI | 52.14 | -0.13 | -0.25% |
| BondBloxx BBB Rated 5-10 Yr Corp Bd ETF | |||
CAPN and
Correlation & Price change
A.I.dvisor indicates that over the last year, CAPN has been loosely correlated with NHICU. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CAPN jumps, then NHICU could also see price increases.
| Ticker / NAME | Correlation To CAPN | 1D Price Change % | ||
|---|---|---|---|---|
| CAPN | 100% | N/A | ||
| NHICU - CAPN | 65% Loosely correlated | N/A | ||
| IPOD - CAPN | 41% Loosely correlated | +0.10% | ||
| WST - CAPN | 32% Poorly correlated | -2.10% | ||
| ATMCU - CAPN | 21% Poorly correlated | N/A | ||
| STE - CAPN | 16% Poorly correlated | -0.73% | ||
More | ||||